PER 13.5% 6.4¢ percheron therapeutics limited

Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-10

  1. 4,680 Posts.
    lightbulb Created with Sketch. 1083
    This will go bonkers when news hits the USA.

    Sarepta has had all sorts of problems recently .....and their drug is only applicable to 13% of the boys.

    ANP will be in the spoptlight big time.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
6.4¢
Change
-0.010(13.5%)
Mkt cap ! $57.69M
Open High Low Value Volume
7.4¢ 7.6¢ 5.9¢ $516.4K 8.992M

Buyers (Bids)

No. Vol. Price($)
2 339429 6.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 143169 1
View Market Depth
Last trade - 16.10pm 25/04/2024 (20 minute delay) ?
Last
5.9¢
  Change
-0.010 ( 21.3 %)
Open High Low Volume
7.6¢ 7.6¢ 5.9¢ 132018
Last updated 15.49pm 25/04/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.